Assert-IQ vs Aorta-CAD

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Assert-IQ

by Abbott

Aorta-CAD

by Imagen Technologies

AI Verdict

Assert-IQ provides long-term, continuous cardiac rhythm monitoring through an insertable device to detect arrhythmias. Conversely, Aorta-CAD is an AI-powered software that assists in identifying signs of aortic atherosclerosis and ectasia on chest X-rays. While both fall under Cardiology AI, they address distinct diagnostic challenges and utilize different methodologies (physiological monitoring vs. imaging analysis).

Choose Assert-IQ if…

Choose Assert-IQ if your patient requires long-term, continuous cardiac monitoring for up to six years to diagnose and manage suspected heart rhythm disorders. This system is ideal for comprehensive arrhythmia detection and remote patient management, allowing for proactive clinician alerts and patient-logged symptoms.

View Assert-IQ →

Choose Aorta-CAD if…

Choose Aorta-CAD if your clinical practice frequently interprets chest X-rays and you seek AI-powered assistance to enhance the detection of Aortic Atherosclerosis and Aortic Ectasia. This cloud-based software seamlessly integrates into existing radiology workflows, providing an overlay to highlight potential findings and reduce diagnostic misses.

View Aorta-CAD →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Assert-IQ	Aorta-CAD
Deployment	Subcutaneously implanted device with mobile app connectivity	Cloud-based software that integrates into existing chest X-ray workflows and Picture Archiving and Communication System (PACS) viewers.
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Unknown	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Assert-IQ

Assert-IQ (Tool A) offers a comprehensive approach to usability, providing a patient-facing myMerlin mobile app for symptom logging and data transmission, along with remote programming capabilities for clinicians. Abbott also provides a 'SyncUP' remote support service to assist patients with app setup, enhancing the overall user experience for both patients and providers.

Clinical Value

Aorta-CAD

Aorta-CAD (Tool B) demonstrates strong, quantified clinical value with a reported 62% relative reduction in misses for aortic calcification and a 35% relative reduction in misses for dilated aorta in clinical studies. Furthermore, 96% of physicians showed improvement when assisted by the device, providing clear evidence of its impact on diagnostic accuracy.

Pricing & Value

Tie

Both Assert-IQ (Tool A) and Aorta-CAD (Tool B) require direct contact with their respective companies for pricing information, and neither offers transparent pricing details or free trials. Without specific cost data or detailed value propositions, it is impossible to definitively compare their pricing and value.

Enterprise Readiness

Assert-IQ

Assert-IQ (Tool A) benefits from being a product of Abbott Medical, a highly established company founded in 1888 with a global presence and extensive experience in the medical device industry. Its HIPAA compliance, FDA clearance, and hybrid deployment options, coupled with Abbott's robust infrastructure, suggest a more mature and comprehensive enterprise-ready solution.

Innovation

Aorta-CAD

Aorta-CAD (Tool B) showcases significant innovation by leveraging deep learning algorithms to detect and highlight specific aortic conditions on chest X-rays, seamlessly integrating this AI capability into existing diagnostic workflows. This application of AI to enhance diagnostic accuracy on a widely used imaging modality represents a cutting-edge advancement in clinical diagnostics.

Support & Docs

Assert-IQ

Assert-IQ (Tool A) provides extensive support and documentation, including various clinician manuals (User Manual, Merlinu2122 Patient Care System Help Manual) and patient guides (myMerlin Mobile App Patient IFU), all accessible through their website. They also offer a dedicated Remote Care Technical Support Team and email support, indicating a well-structured support system.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Assert-IQ	Aorta-CAD
Product Name	Assert-IQ	Aorta-CAD
Company	Abbott Medical	Imagen Technologies
Primary Use Case	Long-term, continuous cardiac monitoring and advanced arrhythmia detection for suspected heart rhythm disorders.	Assists physicians in detecting signs of Aortic Atherosclerosis and Aortic Ectasia on chest X-rays.
Mobile App Availability	None	Not specified
Data Export	Yes	Not specified
Specialties	Cardiology, Internal Medicine	Cardiology, Internal Medicine, Radiology

Videos

Demos, reviews, and walkthroughs featuring Assert-IQ and Aorta-CAD.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What are the primary clinical applications and target conditions for Assert-IQ versus Aorta-CAD?

Assert-IQ is designed for long-term, continuous cardiac monitoring and advanced arrhythmia detection to aid in diagnosing and managing suspected heart rhythm disorders. Aorta-CAD is an AI software that assists physicians in detecting signs of Aortic Atherosclerosis and Aortic Ectasia on chest X-rays.

What kind of output or assistance do physicians receive from each tool?

Assert-IQ provides remote monitoring capabilities and proactive clinician alerts based on continuous cardiac data, along with patient activator for symptom logging. Aorta-CAD creates annotations via an overlay on chest X-rays, highlighting radiographic findings suggestive of Aortic Atherosclerosis and Aortic Ectasia to assist interpretation.

Are there any specific clinical performance metrics or study results available for either tool?

Assert-IQ offers advanced arrhythmia detection algorithms and long-term continuous monitoring. Aorta-CAD has demonstrated a 62% relative reduction in misses for aortic calcification and a 35% relative reduction in misses for dilated aorta in a clinical study.

Which medical specialties are these tools primarily intended to serve?

Assert-IQ is primarily aimed at Cardiology and Internal Medicine specialties, targeting large health systems, hospitals, and cardiology clinics. Aorta-CAD assists physicians in Cardiology, Internal Medicine, and Radiology, including both radiologists and PCPs.

What is the patient's interaction with each system?

Assert-IQ involves a minimally invasive insertion of the device and includes a patient activator for symptom logging. Aorta-CAD is a software-only tool that analyzes existing chest X-rays, so there is no direct patient interaction with the software itself.